Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S ‐1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer

ConclusionsNeoadjuvant chemotherapy including intraperitoneal paclitaxel followed by sequential intravenous paclitaxel and cisplatin with S ‐1 for resectable advanced gastric cancer is feasible and effective.

Source: Journal of Surgical Oncology - November 15, 2018 Category: Cancer & Oncology Authors: Masayuki Shinkai, Motohiro Imano, Yasutaka Chiba, Mitsuru Iwama, Osamu Shiraisi, Atsushi Yasuda, Masanobu Tsubaki, Shozo Nishida, Yutaka Kimura, Takushi Yasuda Tags: RESEARCH ARTICLE Source Type: research